ID

21229

Description

Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00601406

Link

https://clinicaltrials.gov/show/NCT00601406

Keywords

  1. 4/13/17 4/13/17 -
Uploaded on

April 13, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00601406

Eligibility Breast Cancer NCT00601406

Criteria
Description

Criteria

patients must have received curative external-beam radiotherapy within the context of a formal clinical study for any of the following:
Description

curative radiotherapy in clinical study

Data type

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C1522449
early breast cancer after breast-conserving surgery
Description

early breast cancer after breast-conserving surgery

Data type

boolean

Alias
UMLS CUI [1,1]
C4016951
UMLS CUI [1,2]
C0917927
localized prostate cancer
Description

prostate cancer

Data type

boolean

Alias
UMLS CUI [1]
C0600139
gynecological cancer (may have also received brachytherapy)
Description

gynecological cancer, brachytherapy

Data type

boolean

Alias
UMLS CUI [1,1]
C0006826
UMLS CUI [1,2]
C0017411
UMLS CUI [1,3]
C0006098
venous blood samples must be available
Description

venous blood samples available

Data type

boolean

Alias
UMLS CUI [1,1]
C0444255
UMLS CUI [1,2]
C0470187
patients will be identified from the following clinical studies:
Description

patient identification studies

Data type

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C1269815
cambridge intensity-modulated radiotherapy breast randomized trial
Description

radiotherapy to breast trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0948310
rt01 prostate radiotherapy randomized trial/other prostate trials
Description

radiotherapy to prostate trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0948317
christie hospital breast, prostate, and gynecological cancer radiotherapy patients
Description

radiotherapy to breast, prostate, gynecological cancer trial

Data type

boolean

Alias
UMLS CUI [1,1]
C0008972
UMLS CUI [1,2]
C0948310
UMLS CUI [1,3]
C0948317
UMLS CUI [1,4]
C1522449
UMLS CUI [1,5]
C0017411
UMLS CUI [1,6]
C0006826
must have minimum follow up with late normal tissue effect scoring for two years available
Description

follow up available

Data type

boolean

Alias
UMLS CUI [1]
C0589120
patient characteristics:
Description

patient characteristics

Data type

boolean

Alias
UMLS CUI [1]
C0815172
no other malignancy prior to treatment for the specified tumor types except basal cell or squamous cell carcinoma of the skin or in situ carcinoma
Description

other malignancies

Data type

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C0006826
prior concurrent therapy:
Description

concurrent therapy

Data type

boolean

Alias
UMLS CUI [1]
C0009429
see disease characteristics
Description

disease characteristics

Data type

boolean

Alias
UMLS CUI [1]
C1705348

Similar models

Eligibility Breast Cancer NCT00601406

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
curative radiotherapy in clinical study
Item
patients must have received curative external-beam radiotherapy within the context of a formal clinical study for any of the following:
boolean
C0008972 (UMLS CUI [1,1])
C1522449 (UMLS CUI [1,2])
early breast cancer after breast-conserving surgery
Item
early breast cancer after breast-conserving surgery
boolean
C4016951 (UMLS CUI [1,1])
C0917927 (UMLS CUI [1,2])
prostate cancer
Item
localized prostate cancer
boolean
C0600139 (UMLS CUI [1])
gynecological cancer, brachytherapy
Item
gynecological cancer (may have also received brachytherapy)
boolean
C0006826 (UMLS CUI [1,1])
C0017411 (UMLS CUI [1,2])
C0006098 (UMLS CUI [1,3])
venous blood samples available
Item
venous blood samples must be available
boolean
C0444255 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
patient identification studies
Item
patients will be identified from the following clinical studies:
boolean
C0008972 (UMLS CUI [1,1])
C1269815 (UMLS CUI [1,2])
radiotherapy to breast trial
Item
cambridge intensity-modulated radiotherapy breast randomized trial
boolean
C0008972 (UMLS CUI [1,1])
C0948310 (UMLS CUI [1,2])
radiotherapy to prostate trial
Item
rt01 prostate radiotherapy randomized trial/other prostate trials
boolean
C0008972 (UMLS CUI [1,1])
C0948317 (UMLS CUI [1,2])
radiotherapy to breast, prostate, gynecological cancer trial
Item
christie hospital breast, prostate, and gynecological cancer radiotherapy patients
boolean
C0008972 (UMLS CUI [1,1])
C0948310 (UMLS CUI [1,2])
C0948317 (UMLS CUI [1,3])
C1522449 (UMLS CUI [1,4])
C0017411 (UMLS CUI [1,5])
C0006826 (UMLS CUI [1,6])
follow up available
Item
must have minimum follow up with late normal tissue effect scoring for two years available
boolean
C0589120 (UMLS CUI [1])
patient characteristics
Item
patient characteristics:
boolean
C0815172 (UMLS CUI [1])
other malignancies
Item
no other malignancy prior to treatment for the specified tumor types except basal cell or squamous cell carcinoma of the skin or in situ carcinoma
boolean
C0009488 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
concurrent therapy
Item
prior concurrent therapy:
boolean
C0009429 (UMLS CUI [1])
disease characteristics
Item
see disease characteristics
boolean
C1705348 (UMLS CUI [1])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial